Caitong International Asset Management’s Neuphoria Therapeutics NEUP Stock Holding History

Caitong International Asset Management’s Portfolio NEUP Stock Details NEUP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13	Buy	+3	New	+$14	﹤0.01%	2604

Other funds holding NEUP

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Caitong International Asset Management's NEUP Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Neuphoria Therapeutics (NEUP) in Q2 2026: 3 shares worth $13. The stake represents ﹤0.01% of the portfolio and ranks #2604 among its holdings.

3 funds tracked by Wall St. Rank hold NEUP as of Q2 2026.

Caitong International Asset Management held 3 shares of Neuphoria Therapeutics worth $13 as of Q2 2026.
Neuphoria Therapeutics was a new Caitong International Asset Management position in Q2 2026.
Neuphoria Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2604 holding.
3 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.